Brought to you by 
ArQule signs its first major deal with Pharmacia for R&D
13 Jul 1999
Executive Summary
ArQule Inc., (combinatorial chemistry company founded 1993) signed its first major deal worth approximately $30 million with Sweden's Pharmacia Biotech to synthesize biomolecules for use in bioprocessing and research.
Deal Industry
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Biotechnology
- Synthesis Technologies, Production Processes
-
Drug Discovery Tools
- Molecular Diversity
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
ArQule signs its first major deal with Pharmacia for R&D
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice